Biotox Bac Liquid
NDC Package 50181-0077-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

Biotox Bac (bacillus tetani, chlamydia trachomatis, streptococcus viridans, meningococcus nosode, phytolacca decandra, pneumococcinum, clostridium perfringens, dysentery bacillus, enterococcus faecalis, listeria monocytogenes, streptococcus agalactiae, streptococcus dysgalactiae, streptococcus mutans, streptococcus bovis, streptococcus uberis) liquids is for the temporary relief of fever, sore throat, fatigue, pain and loose stools.  For the temporary relief of fever, sore throat, fatigue, pain and loose stools. This formulation utilizes a liquid delivery system. Marketed by The Wellness Center For Research And Education, Inc., this product is identified by NDC 50181-0077.

Identification & Billing

NDC Package Code
50181-0077-1
Package Description
30 mL in 1 BOTTLE, DROPPER
Product Code
50181-0077
11-Digit Billing Format
50181007701

Clinical Specifications

Proprietary Name
Biotox Bac 2
Non-Proprietary Name
Bacillus Tetani, Chlamydia Trachomatis, Streptococcus Viridans, Meningococcus Nosode, Phytolacca Decandra, Pneumococcinum, Clostridium Perfringens, Dysentery Bacillus, Enterococcus Faecalis, Listeria Monocytogenes, Streptococcus Agalactiae, Streptococcus Dysgalactiae, Streptococcus Mutans, Streptococcus Bovis, Streptococcus Uberis
Substance Name
Clostridium Tetani; Chlamydia Trachomatis; Streptococcus Viridans Group; Neisseria Meningitidis; Phytolacca Americana Root; Streptococcus Pneumoniae; Clostridium Perfringens; Shigella Dysenteriae; Enterococcus Faecalis; Listeria Monocytogenes; Streptococcus Agalactiae; Streptococcus Dysgalactiae; Streptococcus Mutans; Streptococcus Equinus; Streptococcus Uberis
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
For the temporary relief of fever, sore throat, fatigue, pain and loose stools.  For the temporary relief of fever, sore throat, fatigue, pain and loose stools.

Regulatory & Marketing

Labeler Name
The Wellness Center For Research And Education, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
10-04-2021
End Marketing Date
10-26-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50181-0077-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Biotox Bac 2, a human over the counter drug labeled by The Wellness Center For Research And Education, Inc.. This liquid is formulated for oral use and contains clostridium tetani; chlamydia trachomatis; streptococcus viridans group; neisseria meningitidis; phytolacca americana root; streptococcus pneumoniae; clostridium perfringens; shigella dysenteriae; enterococcus faecalis; listeria monocytogenes; streptococcus agalactiae; streptococcus dysgalactiae; streptococcus mutans; streptococcus equinus; streptococcus uberis as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Wellness Center For Research And Education, Inc. on October 04, 2021.

How is this The Wellness Center For Research And Education, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50181007701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50181-0077-1
11-Digit CMS (5-4-2)
50181-0077-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.